Available in 13 different languages, CANRISK is a questionnaire that pharmacists can use to help patients identify their risk of pre-diabetes or type 2 diabetes. It is intended for adults aged 45 to 74, but may also be used for younger groups in high-risk populations. By implementing the CANRISK questionnaire in your community pharmacy, you will be playing a key role in the prevention and early detection of diabetes.
Developed by the Public Health Agency of Canada (PHAC), CANRISK was adapted from a similar questionnaire used in Finland as part of its national diabetes prevention program (FINDRISC). PHAC convened a group of clinical and academic experts to modify the questionnaire so it would more accurately reflect known diabetes risk factors applicable to Canadians; this included adding new questions on ethnicity, education and gestational diabetes.
CANRISK scores have been validated against diagnostic gold standard blood tests in a recent Canadian study for use in assessing diabetes risk in Canada's multi-ethnic population. This peer-reviewed study involved more than 6000 blood-tested adults (Chronic Diseases and Injuries in Canada, Dec. 2011).
CPhA has developed a 3 CEU online training program to effectively use the CANRISK diabetes screening questionnaire in community pharmacy practice, including communicating results, triaging individuals requiring referrals, and developing strategies to incorporate use of the CANRISK tool into your medication management service delivery. Find out how to register for this 3.0 CEU program.
English (standard PDF) (interactive PDF)
French (standard PDF) (interactive PDF)
Download the questionnaires to your computer or tablet in order to have them readily available for screening in your pharmacy. You can also access the English and French questionnaires online via PHAC's CANRISK website (en français).
* Documents noted with an asterisk are slightly modified versions of the orginal CANRISK tool, created by the Canadian Task Force on Preventative Health Care (CTFPHC).
When completing or reviewing the results of the CANRISK questionnaire with your patients, be sure to discuss the following:
• The benefits of early screening
• The difference between modifiable and nonmodifiable risk factors
• How certain lifestyle changes can reduce a person's risk
• Appropriate next steps based on the CANRISK results
Your Guide to Diabetes was developed by the Public Health Agency of Canada.
This guide will help patients who have completed the CANRISK questionnaire better understand diabetes, how to prevent it and how best to manage it if diagnosed.
CPhA developed an expanded CANRISK User Guide for Pharmacists to provide an overview of the development of the questionnaire, an understanding of the weighted score associated with each CANRISK question, the key messages and clarifications to impart when reviewing CANRISK with your patients as well as tips on how to easily encorporate CANRISK into community pharmacy practice.
CTFPHC version of CANRISK - The Canadian Task Force on Preventative Health Care (CTFPHC) has developed, with PHAC endorsement, a slightly modified version of the CANRISK tools. This CTFPHC CANRISK tool has been translated into Arabic, Simple Chinese and Punjabi.
Recommendations on Screening for Type 2 Diabetes in Adults - Developed by the CTFPHC and published in the Canadian Medical Association Journal.
FAQ for Patients - Developed by the CTFPHC.